Industry News

Endeavor BioMedicines Doses First Patient in Phase 2 Clinical Trial of Taladegib (ENV-101) for Idiopathic Pulmonary Fibrosis; Appoints Chief Medical Officer

SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines, a clinical-stage precision medicine company targeting the core drivers of multiple terminal diseases including oncology and fibrosis, announced that the...

Admin - September 22, 2021

Industry News

Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy...

Admin - September 22, 2021

Industry News

EXKIVITY® (mobocertinib) Approved for Previously-Treated Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Takeda to be a specialty pharmacy partner for EXKIVITY® (mobocertinib), the...

Admin - September 22, 2021

Industry News

Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development

TORONTO & SHANGHAI--(BUSINESS WIRE)--Cyclica, the partner of choice for data-driven drug discovery, and IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development...

Admin - September 22, 2021

Industry News

Poxel Completes Enrollment in Phase 2 NASH Trial for PXL065 (DESTINY-1) in Biopsy-Proven Patients

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext – POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including...

Admin - September 21, 2021

Industry News

Clinical Investigation Shows Herb-Pharma’s ViroStop Spray Effective in Reducing Impact of Covid-19

ZURICH--(BUSINESS WIRE)--A recent clinical study has shown that the ViroStop anti-viral spray from Swiss company, Herb-Pharma is effective in reducing the impact of Covid-19...

Admin - September 21, 2021

123...309 Page 2 of 309

Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19

Editor´s Pick September 22, 2021

Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)

Regulatory Affairs September 22, 2021

bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood...

Industry News September 22, 2021

LabGenius Appoints Dr. Didier Landais as Chief Operating Officer

Look Who’s On the Move! September 22, 2021

Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries

Editor´s Pick September 22, 2021

Taysha Receives Orphan Drug Designation from the European Commission for TSHA-102 for the Treatment of Rett Syndrome

Look Who’s On the Move! September 22, 2021

Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer

Look Who’s On the Move! September 22, 2021

Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine...

Industry News September 22, 2021

Dicerna Announces New Executive Leadership Appointments

Look Who’s On the Move! September 22, 2021

Ferring to Present Award-Winning, Landmark Research for Investigational Microbiota-Based Live Biotherapeutic RBX2660 at IDWeek 2021

Industry News September 22, 2021

CG Oncology and Roche to Collaborate on Clinical Trial of Oncolytic Immunotherapy CG0070 as Part of Novel Combination for Various Solid Tumor Indications

Industry News September 22, 2021

Industry News

Recent Articles

Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19

Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)

bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood...

LabGenius Appoints Dr. Didier Landais as Chief Operating Officer

Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries

Taysha Receives Orphan Drug Designation from the European Commission for TSHA-102 for the Treatment of Rett Syndrome

Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer

Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine...

Dicerna Announces New Executive Leadership Appointments

Ferring to Present Award-Winning, Landmark Research for Investigational Microbiota-Based Live Biotherapeutic RBX2660 at IDWeek 2021

CG Oncology and Roche to Collaborate on Clinical Trial of Oncolytic Immunotherapy CG0070 as Part of Novel Combination for Various Solid Tumor Indications

Vividion Therapeutics Announces Formation of Scientific Advisory Board

Ocular Therapeutix™ Appoints Merilee Raines to Its Board of Directors

AnHeart Therapeutics Announces Formation of Scientific Advisory Board

Peptilogics to Present First-in-Human Phase 1 Clinical Data of PLG0206 at IDWeek 2021